MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer

Expert Opinion on Therapeutic Targets

Volumn 19, Issue 12, 2015, Pages 1705-1723

  Jafri, Mohammad Alam ^a   Zaidi, Syed Kashif ^a   Ansari, Shakeel Ahmed ^a   Al Qahtani, Mohammed Hussein ^a   Shay, Jerry W ^a,b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

antagomirs; anti microRNA oligonucleotides; colon cancer; genomic instability; microRNA dysregulation; microRNA mimics; microRNA silencing; replacement therapy

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; APC PROTEIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; K RAS PROTEIN; KRUPPEL LIKE FACTOR 4; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE 14; MICRORNA; MICRORNA 107; MICRORNA 1288; MICRORNA 141; MICRORNA 143; MICRORNA 145; MICRORNA 182; MICRORNA 192; MICRORNA 200C; MICRORNA 20A; MICRORNA 210; MICRORNA 221; MICRORNA 34A; MICRORNA 375; PROTEIN P53; STROMELYSIN 3; TRANSCRIPTION FACTOR E2F4; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANGIOGENESIS; ANTISENSE THERAPY; CANCER GROWTH; CELL MIGRATION; CHROMOSOMAL INSTABILITY; COLON CARCINOGENESIS; COLORECTAL CANCER; GENE ACTIVATION; GENE SILENCING; HUMAN; IMMUNE RESPONSE; METASTASIS; MOLECULARLY TARGETED THERAPY; REVIEW; RNA SYNTHESIS; TUMOR INVASION; ANIMAL; COLORECTAL NEOPLASMS; DISEASE COURSE; GENETICS; ONCOGENE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; ONCOGENES; SIGNAL TRANSDUCTION;

EID: 84951733168     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2015.1069816     Document Type: Review

References (135)

1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2015. Ca Cancer J Clin 2015;65:5-29
2. Fang L, Yang N, Ma J, et al. microRNA-1301-mediated inhibition of tumorigenesis. Oncol Rep 2012;27:929-34
3. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-66
4. Schetter AJ, Okayama H, Harris CC. The role of microRNAs in Colorectal Cancer. Cancer J 2012;18(3):244-52
5. Li T, Leong MH, Harms B, et al. MicroRNA-21 as a potential colon and rectal cancer biomarker. World J Gastroenterol 2013;19(34):5615-21
6. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006;6(4):259-69
7. Mazeh H, Mizrahi I, Ilyayev N, et al. The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer-a Comprehensive review. J Cancer 2013;4(3):281-95
8. Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004;23(20):4051-60
9. Han J, Lee Y, Yeom KH, et al. Molecular basis for the recognition of primary microRNAs by Drosha-DGCR8 complex. Cell 2006;125:887-901
10. Bohnsack MT, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004;10(2):185-1891
11. Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000;404:293-6
12. Gregory RI, Chendrimada TP, Cooch N, et al. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005;123:631-40
13. Liu J, Valencia-Sanchez MA, Hannon GJ, et al. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 2005;7(7):719-23
14. Tokarz P, Blasiak J. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Acta Biochimia Polonica 2012;59(4):467-74
15. Dong H, Lei J, Ding L, et al. MicroRNA: Function, Detection and Bioanalysis. Chem Rev 2013;113:6207-33
16. Jiang R, Li Y. Regulation of Mirna pathways and roles of Micrornas in tumorigenesis and metastasis. Human Genet Embryol 2013.S2. Available from: http://dx.doi.org/10.4172/2161-0436.S2-007
17. Wang Z, Cummins JM, Shen D, et al. Three classes of genes mutated in colorectal cancers with chromosomal instability. Cancer Res 2004;64:2998-3001
18. Oberg AL, French AJ, Sarver AL, et al. miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS One 2011;6(6):e20465
19. Jaitin DA, Kenigsberg E, Keren-Shaul H, et al. Massively parallel single-cell RNAseq for marker-free decomposition of tissues into cell types. Science 2014;343:776-9
20. Michael MZ, SM OC, van Holst Pellekaan NG, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol cancer res: MCR 2003;1:882-91
21. Cui SY, Wang R, Chen LB. MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways. J Cell Mol Med 2014;18(10):1913-26
22. Sachdeva M, Mo Y. MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1. Cancer Res 2010;70(1):378-87
23. Feng Y, Zhu J, Ou C, et al. MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1. Br J Cancer 2014;110:2300-9
24. Oliver A, Kent I, Matthew N, et al. Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucleic Acids Res 2014;42(12):7528-38
25. Arndt GM, Dossey L, Cullen LM, et al. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 2009;9:374
26. Chivukula RR, Shi G, Acharya A, et al. An Essential Mesenchymal Function for miR-143/145 in Intestinal Epithelial Regeneration. Cell 2014;157(5):1104-16
27. Scarpati GDV, Calura E, Marino MD, et al. Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients. BioMed Res Int 2014;2014:840921
28. Sun Y, Wang L, Guo SC, et al. High-throughput sequencing to identify miRNA biomarkers in colorectal cancer patients. Oncol lett 2014;8:711-13
29. Chai J, Wang S, Han D, et al. MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonineprotein kinase. Tumor Biol 2015;36(2):1313-21
30. Christensen LL, Holm A, Rantala J, et al. Functional Screening Identifies miRNAs Influencing Apoptosis and Proliferation in Colorectal Cancer. PLoS One 2014;9(6):e96767
31. Wang B, Shen ZL, Gao ZD, et al. MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway. Cell Cycle 2015;14(7):1046-58
32. Zhang G, Zhou H, Xiao H, et al. MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer. BMC Cancer 2014;14:109
33. Lee DY, Deng Z, Wang CH, et al. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA 2007;104(51):20350-5
34. Chen LT, Xu SD, Xu H, et al. MicroRNA-378 is associated with nonsmall cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis. Med Oncol 2012;29(3):1673-80
35. Eichner LJ, Perry MC, Dufour CR, et al. miR-378 mediates metabolic shift in breast cancer cells via the PGC-1beta/ERR gamma transcriptional pathway. Cell Metab 2010;12(4):352-61
36. Deng H, Guo Y, Song H, et al. MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. Gene 2013;518(2):351-9
37. Faltejskova P, Svoboda M, Srutova K, et al. Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J Cell Mol Med 2012;16(11):2655-66
38. O'Donnell KA, Wentzel EA, Zeller KI, et al. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005;435:839-43
39. Tazawa H, Tsuchiya N, Izumiya M, et al. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007;104:15472-7
40. Sachdeva M, Zhu S, Wu F, et al. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 2009;106:3207-12
41. Bandres E, Agirre X, Bitarte N, et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 2009;125:2737-43
42. Grady WM, Parkin RK, Mitchell PS, et al. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 2008;27(27):3880-8
43. Landi D, Gemignani F, Naccarati A, et al. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 2008;29(3):579-84
44. Lee HC, Kim JG, Chae YS, et al. Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer. J Cancer Res 2010;136:1073-8
45. Wang P, Zou F, Zhang X, et al. MicroRNA-21 negatively regulates CDC25A and cell cycle progressionin colon cancer cells. Cancer Res 2009;69:8157-65
46. Xiong B, Cheng Y, Ma L, et al. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells. Int J Oncol 2013;42(1):219-28
47. Sun D, Yu F, Ma Y, et al. MicroRNA-31 activates the Ras pathway and functions as an oncogenic microRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). J Biol Chem 2013;288:9508-18
48. Nagel R, le Sage C, Diodado B, et al. Regulation of the adenomatous polyposis coli gene by miR-135 family in colorectal cancer. Cancer Res 2008;68:5795-802
49. Zhang G, Zhou H, Xiao H, et al. Up-regulation of miR-224 promotes cancer cell proliferation and invasion and predicts relapse of colorectal cancer. Cancer Int 2013;13:104
50. Liu M, Lang N, Chen X, et al. miR-185 targets RhoA and cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer lett 2011a;301:151-60
51. Li Y, Zhu X, Xu W, et al. miR-330regulates the proliferation of colorectal cancer cells by targetingCdc42. Biochem Biophys Commun 2013;431:560-5
52. Wang L, Qian L, Li Q, et al. MicroRNA-195 inhibits colorectal cancer cell proliferation, colony-formation and invasion through targeting CARMA3. Mol Med Reports 2014;10(1):473-8
53. Nagel R, le Sage C, Diosdado B, et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 2008;68:5795-802
54. Valeri N, Braconi C, Gasparini P, et al. MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. Cancer Cell 2014;25(4):469-83
55. Chen X, Guo X, Zhang H, et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009;28:1385-92
56. Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med 2009;13:39-53
57. Guo C, Sah JF, Beard L, et al. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chrom Can 2008;47:939-46
58. Akao Y, Noguchi S, Iio A, et al. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. Cancer Lett 2011;300:197-204
59. Li L, Sarver AL, Khatri R, et al. Sequential expression of miR-182 and miR-503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma. J Pathol 2014;234(4):488-501
60. Wuy J, Wu G, Lv L, et al. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis 2012;33(3):519-28
61. Zhang W, Zhang T, Jin R, et al. MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer. J Exp Clin Cancer Res 2014;33:113
62. Xu K, Liu X, Mao X, et al. MicroRNA-149 suppresses colorectal cancer cell migration and invasion by directly targeting forkhead box transcription factor FOXM1. Cell Physiol Biochem 2015;35:499-515
63. Zhang Q, Yu L, Qin D, et al. Role of microRNA-30c targeting ADAM19 in colorectal cancer. PLoS One 2015;10(3):e0120698
64. Zhang C, Liu J, Wang X, et al. MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling. Oncotarget 2014;5(19):9106-17
65. Zhang GJ, Xiao HX, Tian HP, et al. Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression. Int J Mol Med 2013;3:1375-80
66. Qin J, Wang F, Jiang H, et al. MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells. Int J Clin Exp Pathol 2015;8(2):1328-40
67. Zhou Y, Feng X, Liu Y, et al. Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways. PLoS One 2013;8(1):e81203
68. Ji S, Ye G, Zhang J, et al. miR-574-5p negatively regulates Qki6/7 to impact b-catenin/Wnt signalling and the development of colorectal cancer. Gut 2013;62:716-26
69. Zhou JJ, Zheng S, Sun LF, et al. MicroRNA regulation network in colorectal cancer metastasis. World J Biol Chem 2014;5(3):301-7
70. Zaravinos A. The regulatory role of MicroRNAs in EMT and cancer. J Oncol 2015;2015:865816
71. Hur K, Toiyama Y, Takahashi M, et al. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut 2013;62(9):1315-26
72. Yamakuchi M, Lowenstein CJ. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 2009;8:712-15
73. Yamakuchi M, Ferlito M, Lowenstein CJ. MiR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008;105:13421-6
74. Raver-Shapira N, Marciano E, Meiri E, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007;26:731-43
75. Sundaram P, Hultine S, Smith LM, et al. p53-responsive miR-194 inhibits thrombospondin-1and promotes angiogenesis in colon cancers. Cancer Res 2011;71:7490-501
76. Zhao HJ, Ren LL, Wang ZH, et al. MiR-194 deregulation contributes to colorectal carcinogenesis via targeting AKT2 pathway. Theranostics 2014;4(12):119301208
77. Chiang Y, Song Y, Wang Z, et al. microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer. Exp Ther Med 2012;3:560-6
78. Zhang H, Hao Y, Yang J, et al. Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. Nat Commun 2011;2:554
79. Zhang Y, Wang X, Xu B, et al. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer. Oncol Rep 2013;30:1976-84
80. Dews M, Homayouni A, Yu D, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006;38:1060-5
81. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, et al. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 2009;101:707-14
82. Zhou JJ, Zheng S, Sun LF, et al. MicroRNA regulation network in colorectal cancer metastasis. World J Biol Chem 2014;5(3):301-7
83. Wang J, Zhao J, Shi J, et al. Elevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis. PLoS One 2014;9(2):e89223
84. Ramalingam S, Subramaniam D, Anant S, et al. RBM3 drives tumor angiogenesis by modulating miR-210. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR. Cancer Res 2013;73(8 Suppl):abstract nr 3901
85. Ye J, Wu X, Wu D, et al. miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer. PLoS One 2013;8(4):e60687
86. Qiana X, Yuab J, Yinac Y, et al. MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers. Cell Cycle 2013;12(9):1385-94
87. Xiao F, Qiu H, Cui H, et al. MicroRNA-885-3p inhibits the growth of HT-29 colon cancer cell xenografts by disrupting angiogenesis via targeting BMPR1A and blocking BMP/Smad/Id1 signaling. Oncogene 2015;34(15):1968-78
88. Williams AE, Perry MM, Moschos SA, et al. Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans 2008;36:1211
89. Li L, Chen XP, Li YJ, et al. MicroRNA-146a and human disease. Scand J Immunol 2010;71:227-31
90. Rusca N, Monticelli M. MiR-146a in immunity and disease. Mol Biol Int 2011;2011:437301
91. Okayama H, Schetter AJ, Harris CC, et al. MicroRNAs and inflammation in pathogenesis and progression of colon cancer. Dig Dis 2012;30(Suppl 2):9-15
92. Ma X, Yan F, Deng Q. Modulation of tumorigenesis by the pro-inflammatory microRNA miR-301a in mouse models of lung cancer and colorectal cancer. Cell Discov 2015;1:15005
93. Gao F, Zhao ZL, Zhao WT, et al. miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 2013;431:610-16
94. Ueda R, Kohanbash G, Sasaki K, et al. Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by downregulation of ICAM-1. Proc Natl Acad Sci USA 2009;106:10746-51
95. Remco Nagel R, Sage CL, Diosdado B, et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 2008;68(14):5795-802
96. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006
97. Ng EK, Chong WW, Jin H, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009;58:1375-81
98. Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010;127:118-26
99. Pu XX, Huang GL, Guo HQ, et al. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 2010;25:1674-80
100. Cheng H, Zhang L, Cogdell DE, et al. Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 2011;6:e17745
101. Kanaan Z, Rai SN, Eichenberger MR, et al. Plasma miR-21: a potential diagnostic marker of colorectal cancer. Ann Surg 2012;256:544-51
102. Li T, Leong MH, Harms B, et al. MicroRNA-21 as a potential colon and rectal cancer biomarker. World J Gastroenterol 2013;19(34):5615-21
103. Shivapurkar N, Weiner LM, Marshall JL, et al. Recurrence of early stage colon cancer predicted by expression pattern of circulation microRNAs. PLoS One 2014;9(1):e84686
104. Nonaka R, Nishimura J, Kagawa Y, et al. Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer. Oncol Rep 2014;32(6):2354-8
105. Xu L, Li M, Wang M, et al. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer. BMC Cancer 2014;14:714
106. Zheng G, Du L, Yang X, et al. Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma. Br J Cancer 2014;111:1985-92
107. Ogata-Kawata H, Izumiya M, Kurioka D, et al. Circulating exosomal microRNAs as Biomarkers of Colon Cancer. PLoS One 2014;9(4):e92921
108. Wu CW, Ng SSM, Dong YJ, et al. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 2012;61:739-45
109. Koga Y, Yasunaga M, Takahashi A, et al. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Cancer Prev Res 2010;3:1435-42
110. Ahmed FE, Ahmed NC, Vos PW, et al. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of Principle. Cancer Genomics Proteomics 2013;10:93-113
111. Dassow H, Aigner A. MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy. Curr Pharm Des 2013;19(7):1242-52
112. Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006;3:87-98
113. Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010;9:775-89
114. Petri A, Lindow M, Kauppinen S. MicroRNA silencing in primates: towards development of novel therapeutics. Cancer Res 2009;69:393-5
115. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2009;327:198-201
116. Chai H, Liu M, Tian R, et al. miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines. Acta Biochim Biophys Sin (Shanghai) 2011;43(3):217-25
117. Wang CJ, Stratmann J, Zhou ZG, et al. Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells. BMC Cancer 2010;10:616
118. Bader AG, Brown D, Winkler M. The promise of microRNA replacement therapy. Cancer Res 2010;70:7027-30
119. Akao Y, Nakagawa Y, Naoe T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 2006;29:903-6
120. Hu G, Chen D, Li X, et al. miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo. Cancer Biol Ther 2010;10(2):190-7
121. Liu M, Lang N, Qiu M, et al. miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells. Int J Cancer 2011;128(6):1269-79
122. Zhang J, Guo H, Zhang H, et al. Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene. Cancer 2011;117(1):86-95
123. Liu M, Lang N, Chen X, et al. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer Lett 2011;301(2):151-60
124. Boni V, Bitarte N, Cristobal I, et al. miR-192/miR-215 influence 5-fluorouracil resistance through cell cyclemediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol Cancer Ther 2010;9(8):2265-75
125. Liu L, Chen L, Xu Y, et al. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun 2010;400(2):236-40
126. Lin CW, Hong TM, Yang PC. MicroRNA 135b as therapeutic target in cancers. RNA Dis 2014;1:e410
127. Chen Y, Gao DY, Huang L. In vivo delivery of miRNAs for cancer therapy: challenges and strategies. Adv Drug Deliv Rev 2015;81:128-41
128. Trang P, Wiggins FG, Daige CL, et al. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther 2011;19(6):1116-22
129. Baber IA, Cheng CL, Booth CJ, et al. Nanoparticle-based therapy in an in vivomicroRNA-155 (miR-155)- dependent mouse model of lymphoma. Proc Natl Acad Sci USA 2012;109(26):E1695-704
130. Shi S, Han L, Gong T, et al. Systemic delivery of microRNA-34a for cancer stem cell therapy. Angew Chem Int Ed 2013;52(14):3901-5
131. Takahashi YE, Negishi Y, Nakamura A. Systemic delivery of miR-126 by miRNA-loaded Bubble liposomes for the treatment of hindlimb ischemia. Scientif Rep 2014;4:3883
132. Cheng CJ, Bahal R, Baber IA, et al. MicroRNA silencing for cancer therapy targeted to the tumor microenvironment. Nature 2015;518(7537):107-10
133. Balaguer F, Link A, Lozano JJ, et al. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res 2010;70:6609-18
134. Hu M, Xia M, Chen X, et al. MicroRNA-141 regulates Smad interacting protein 1 (SIP1) and inhibits migration and invasion of colorectal cancer cells. Dig Dis Sci 2010;55:2365-72
135. Karaayvaz M, Pal T, Song B, et al. Prognostic significance of miR-215 in colon cancer. Clin Colorectal Cancer 2011;10:340-407